DuPont, Chemours and Corteva strike $455 million North Carolina PFAS deal

DuPont, Chemours and Corteva have agreed to pay $455 million over 15 years to settle North Carolina PFAS litigation, giving the companies a payment schedule for a major set of claims while leaving continuing cleanup obligations and some lawsuits outside the deal. The agreement announced September 10 calls for $102.5 million initially, making the near-term cash burden heavier than the long repayment period might suggest.

Signed September 9, the agreement covers North Carolina and 11 local entities near Chemours’ Fayetteville Works facility. It addresses their claims over PFAS and other historical discharges from the site, along with the state’s claims over PFAS contamination elsewhere, including contamination associated with aqueous film-forming foam, or AFFF.

The releases can also reach specified claims of additional and remaining state subdivisions, but only where North Carolina’s attorney general has legal authority to release those claims on their behalf. That qualification prevents treating every local government’s claim as automatically extinguished.

The local entities were excluded from the U.S. Public Water System Class Settlement approved in 2024, according to the companies. That makes this agreement a further step in resolving claims left outside that earlier settlement. It was entered without an admission of fault or liability and remains subject to court orders dismissing the covered claims.

Cash payments arrive unevenly

The settlement agreement allocates $380 million to the participating local entities and $75 million to the state. The initial installment comprises $77.5 million for the local entities and $25 million for North Carolina. Payments then total $80.5 million in each of the second and third years before declining. In each of the final five years, the scheduled payment is $4 million, all to the state.

That concentration matters for liquidity: a 15-year settlement does not mean 15 equal annual bills. Chemours said its expected share of payments over the next twelve months is approximately $50 million. The settlement agreement assigns 50% of payments to Chemours, 35.5% to DuPont and 14.5% to Corteva, reflecting their cost-sharing arrangements.

The initial payment is generally due within 30 days of execution. The agreement allows it to go into escrow before the settlement becomes effective, with neither side able to use the money in the meantime. If the required escrow agreement and account are not ready within that period, payment becomes due within five business days after those conditions are satisfied. Subsequent installments fall on anniversaries of execution. The schedule is subject to contractual credits: qualifying judgments, awards or settlements can reduce state installments by 50% of the qualifying amount, up to $6.75 million in total credits. The credit applies to the later of the next state installment or the next annual payment after the fifth payment has been made, limiting near-term relief. The agreement also provides for credits for specified dispute expenses, so the stated schedule is not an unconditional measure of final net cash outflows. If a court’s refusal prevents effectiveness, the agreement provides for cancellation unless the parties agree otherwise; deposited funds and interest must then be returned within 30 days of cancellation and termination.

The initial allocation is not the limit of DuPont’s and Corteva’s payment responsibilities. If Chemours defaults on a settlement payment and the specified notice and 45-day cure process expires, DuPont and Corteva must cover its defaulted share in a 71%/29% split, within 60 days after notice of the uncured default.

Three values measure different obligations

The $455 million is the scheduled cash total. DuPont put the settlement’s net present value at approximately $355 million—a measure that expresses future payments in today’s dollars. The smaller present value does not reduce the promised installments.

Chemours described its share as approximately $180 million on a net present value basis and said it was covered by existing accruals. DuPont put its own pre-tax present value share at approximately $126 million, of which Qnity Electronics must reimburse 44%, and said that share was materially covered by existing accruals. Those statements concern amounts already recognized for expected losses; the companies still face future cash payments.

DuPont’s filing adds that it recorded a probable loss of about $125 million in discontinued operations in the second quarter of 2026, before the Qnity reimbursement obligation. That earlier recorded amount and the approximately $126 million announced present value share are separate disclosures and should not be treated as identical figures.

A third valuation governs how much of the settlement counts against the companies’ cost-sharing arrangement. Chemours said $210 million will count toward the memorandum’s $4 billion aggregate qualified-spend cap. For that calculation, the companies assume equal installments over 25 years and apply an 8% discount rate, rather than use the actual payment schedule. They also agreed to apply that methodology to potential future settlements with multiyear payments.

The distinction has practical consequences: the amount counted against the cost-sharing cap is substantially below the cash owed to North Carolina and its participating local entities. The hypothetical 25-year calculation does not extend their 15-year payment schedule.

Escrow relief comes with continuing obligations

The North Carolina agreement also connects to the companies’ 2025 New Jersey settlement. Payments under the two agreements qualify for withdrawal from their existing memorandum escrow account and exceed their future contribution obligations. Consequently, the companies will treat all future contributions to that account as satisfied by those settlement payments.

For Chemours, that includes a $50 million escrow contribution otherwise due in September 2026. This is separate from its approximately $50 million of expected North Carolina settlement payments over the next twelve months. Satisfying a requirement to fund the shared escrow account does not cancel payments owed under the settlements.

DuPont and Corteva must also establish $135 million of financial assurance for specified Chemours obligations under the 2019 North Carolina consent order. The agreement requires it within 60 days of the effective date, split 71% to DuPont and 29% to Corteva. It specifies a line of credit, letter of credit and/or surety bond. DuPont’s filing also referred to a self-guarantee; that summary differs from the instruments specified in the agreement.

Access to this backstop requires more than a performance failure. The agreement also requires bankruptcy or a judicial determination of inability to pay, notice and an unsuccessful 60-day cure period. The $135 million limit is non-replenishing and falls dollar for dollar with expenditures or specified reductions. A neutral review of estimated remaining costs cannot be initiated before 2033, more than once in three years or more than five times during the reserve’s life. Unless the state, DuPont and Corteva agree otherwise, that process cannot reduce the reserve below $25 million before its termination. The reserve is conditional security rather than an immediate cash payment; these safeguards limit reductions through the neutral-review process.

The agreement’s recitals put Chemours FC’s consent-order compliance spending at approximately $1.193 billion, with further expenditures anticipated. They report sampling approximately 27,500 wells and offering approximately 10,500 replacement drinking water systems. These agreement-recited figures illustrate the scale of the ongoing work; offered systems should not be confused with completed installations.

The agreement distinguishes those backstops from primary cleanup responsibility. Apart from the specified assurance provisions, it releases DuPont, Corteva and EIDP from obligations tied to the consent order or environmental releases from Fayetteville Works. Chemours remains responsible for its remaining consent-order duties.

Chemours said the settlement recognizes completed consent-order provisions and establishes procedures for remaining obligations outside the site, including drinking water programs. In its release, the company said the agreement “provides greater clarity regarding the liabilities associated with these matters” and supports continued operation of Fayetteville Works. The agreement preserves the state’s ordinary regulatory authority over ongoing operations, including permitting.

Claims that remain and milestones ahead

The releases have explicit limits. The agreement preserves all claims of Cape Fear Public Utility Authority and, except as expressly modified, claims enforcing the consent order against Chemours or Chemours FC. Enforcement also survives for specified water-treatment and remediation duties under Bladen County’s September 7, 2021 agreement, and for New Hanover County’s water-connection agreement executed around August 26, 2026. The state retains its ability to take lawful action reasonably necessary to address imminent and substantial dangers to health or the environment.

Of the total settlement, $18 million is attributed to alleged contamination unrelated to Fayetteville Works. DuPont said no more than $14.4 million of the total can be ascribed to AFFF. North Carolina also retains a conditional route to additional recovery: if the companies enter a qualifying PFAS settlement with at least 26 states by the fifth anniversary of this agreement’s effective date, North Carolina can join on the specified terms. North Carolina must join within that settlement’s initial-joinder window. Its allocation is limited to the lower of an equitable percentage specified in the multistate settlement or its population share among participating states and territories, using the 2020 Census. The eligible damages exclude PFAS releases from manufacturing facilities owned or operated by the companies. For installment settlements, additional recovery begins only after North Carolina’s cumulative eligible allocation actually paid exceeds $18 million. Joining would also require the state to accept any broader release under that settlement, including broader covered conduct or narrower preservation of claims. The announced amount therefore does not impose an unconditional ceiling on every future payment to the state.

The agreement also seeks to prevent claims against other defendants from passing covered costs back to the settling companies. If a court nevertheless allows such a contribution or indemnity claim, the claimant must reduce its judgment against the other defendant, or take sufficient other action, to extinguish that claim. This protection can therefore limit claimants’ recoveries elsewhere as well as the companies’ residual exposure.

The immediate milestones are the required litigation dismissals and initial funding arrangements. The agreement defines its effective date by reference to required final, nonappealable dismissal orders; signature alone does not establish that date. The agreement also sets procedures for withdrawing the companies’ pending appeal or petition in the attorney general’s action. As of September 10, the companies continued to describe dismissals as a condition of the settlement; the announcement did not establish that those court steps had been completed.

Separate implementation deadlines begin at execution. The parties have 90 days to work in good faith toward resolving drinking-water disputes and finalizing compliance plans, while North Carolina’s environmental agency must provide its written position on specified remaining obligations within 60 days. Those are planning and position-taking milestones, not deadlines promising that all remediation will be finished.